(0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION (Q4129234)

From EU Knowledge Graph
Revision as of 15:45, 5 February 2022 by DG Regio (talk | contribs) (‎Changed an Item: Edited by the infer coords bot - inferring coordinates from location)
Jump to navigation Jump to search
Project Q4129234 in Italy
Language Label Description Also known as
English
(0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION
Project Q4129234 in Italy

    Statements

    0 references
    5,000.0 Euro
    0 references
    10,000.0 Euro
    0 references
    50.0 percent
    0 references
    LOGIDEX SRL
    0 references
    0 references
    0 references

    45°4'3.94"N, 7°40'56.96"E
    0 references
    (0350000119) COVID:REALIZZAZIONE DI UN COLLUTORIO A BASE DI RESVERATROLO COMPLESSATO CON CICLODESTRINE PER PREVENIRE IL DIFFONDERSI DEL SARS-COV-2 MEDIANTE AEROSOL SALIVARE: SPERIMENTAZIONE PRECLINICA (Italian)
    0 references
    (0350000119) COVID:REALIZZAZIONE DE UN ENJUAGUE BUCAL A BASE DE RESVERATROL COMPLEJO CON CICLODEXTRINA PARA PREVENIR LA PROPAGACIÓN DEL SARS-COV-2 POR AEROSOLES SALIVALES: EXPERIMENTACIÓN PRECLÍNICA (Spanish)
    30 January 2022
    0 references
    (0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION (English)
    31 January 2022
    0 references
    (0350000119) COVID:REALIZZAZIONE D’UN BAIN DE BOUCHE À BASE DE RESVÉRATROL COMPLEXE AVEC DE LA CYCLODEXTRINE POUR PRÉVENIR LA PROPAGATION DU SARS-COV-2 PAR LES AÉROSOLS SALIVAIRES: EXPÉRIMENTATION PRÉCLINIQUE (French)
    1 February 2022
    0 references
    (0350000119) COVID:REALIZZAZIONE EINER RESVERATROL-BASIERTEN MUNDSPÜLUNG, DIE MIT CYCLODEXTRIN KOMPLEX IST, UM DIE AUSBREITUNG VON SARS-COV-2 DURCH SPEICHELAEROSOLE ZU VERHINDERN: PRÄKLINISCHE EXPERIMENTE (German)
    3 February 2022
    0 references
    (0350000119) COVID:REALIZZAZIONE VAN EEN MONDWATER OP BASIS VAN RESVERATROL DAT IS GECOMPLEXEERD MET CYCLODEXTRINE OM VERSPREIDING VAN SARS-COV-2 DOOR SPEEKSELNEVELS TE VOORKOMEN: PREKLINISCHE EXPERIMENTEN (Dutch)
    3 February 2022
    0 references
    TORINO
    0 references

    Identifiers